AU3940597A - Prophylaxis and therapy of the consequences of a lack of cerebral blood circulation and of neurodegenerative diseases - Google Patents

Prophylaxis and therapy of the consequences of a lack of cerebral blood circulation and of neurodegenerative diseases

Info

Publication number
AU3940597A
AU3940597A AU39405/97A AU3940597A AU3940597A AU 3940597 A AU3940597 A AU 3940597A AU 39405/97 A AU39405/97 A AU 39405/97A AU 3940597 A AU3940597 A AU 3940597A AU 3940597 A AU3940597 A AU 3940597A
Authority
AU
Australia
Prior art keywords
prophylaxis
consequences
therapy
lack
blood circulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39405/97A
Inventor
Reni Bartsch
Angelika Rostock
Chris Rundfeldt
Christine Tober
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AWD Pharma GmbH and Co KG
Original Assignee
Arzneimittelwerk Dresden GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden GmbH filed Critical Arzneimittelwerk Dresden GmbH
Publication of AU3940597A publication Critical patent/AU3940597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39405/97A 1996-07-25 1997-07-21 Prophylaxis and therapy of the consequences of a lack of cerebral blood circulation and of neurodegenerative diseases Abandoned AU3940597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19629976 1996-07-25
DE19629976A DE19629976A1 (en) 1996-07-25 1996-07-25 Use of 4- (p-halophenyl) -3-morpholinopyrrole-2-carboxylic acid methyl ester for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases
PCT/EP1997/003918 WO1998004262A1 (en) 1996-07-25 1997-07-21 Prophylaxis and therapy of the consequences of a lack of cerebral blood circulation and of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
AU3940597A true AU3940597A (en) 1998-02-20

Family

ID=7800770

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39405/97A Abandoned AU3940597A (en) 1996-07-25 1997-07-21 Prophylaxis and therapy of the consequences of a lack of cerebral blood circulation and of neurodegenerative diseases

Country Status (5)

Country Link
AR (1) AR008001A1 (en)
AU (1) AU3940597A (en)
DE (1) DE19629976A1 (en)
WO (1) WO1998004262A1 (en)
ZA (1) ZA976582B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011141532A1 (en) 2010-05-12 2011-11-17 Nestec S.A. Capsule, system and method for preparing a beverage by centrifugation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD298912A5 (en) * 1989-11-17 1992-03-19 �������@������������@��k�� PROCESS FOR THE PREPARATION OF 3-AMINOPYRROLES

Also Published As

Publication number Publication date
WO1998004262A1 (en) 1998-02-05
DE19629976A1 (en) 1998-01-29
AR008001A1 (en) 1999-11-24
ZA976582B (en) 1998-02-03

Similar Documents

Publication Publication Date Title
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
HUP0003381A3 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
AU7867994A (en) Hemofiltration of mediator-related diseases
AU2935597A (en) Therapeutic treatment for vegf related diseases
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU4069095A (en) Medicaments for the treatment of restenosis and arterial sclerosis
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
AU2058697A (en) Treatment of sleep disorders
AU7042796A (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
AU2807492A (en) Use of misoprostol for the treatment of allergy
AU4410296A (en) Diagnosis of and therapy for hereditary haemorrhagic telangiectasia
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
EP0689839A3 (en) Use of inhibitors of adenosine triphosphatase for the manufacture of a medicament for the treatment of disorders anociated with beta-amyloid peptide
ZA971607B (en) Methods of treatment of allergic diseases
AUPN104895A0 (en) Methods of and preparations for the treatment of ailments and disorders
AU3940597A (en) Prophylaxis and therapy of the consequences of a lack of cerebral blood circulation and of neurodegenerative diseases
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU2754997A (en) The treatment of plant diseases
ZA947912B (en) Treatment of medical disorders associated with free radical formation
AU6491890A (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
AU3190595A (en) Corneal therapeutic agent
AU5397994A (en) Treatment of skin disorders